| Literature DB >> 25586821 |
Abhilash Sasidharan1, Amal J Sivaram, Archana P Retnakumari, Parwathy Chandran, Giridharan Loghanathan Malarvizhi, Shantikumar Nair, Manzoor Koyakutty.
Abstract
Under ultralow radiofrequency (RF) power, transferrin-conjugated graphene nanoparticles can thermally ablate drug- or radiation-resistant cancer cells very effectively. The results suggest that graphene-based RF hyperthermia can be an efficient method to manage drug-/radiation-resistant cancers.Entities:
Keywords: cancer therapy; drug resistance; graphene; radiofrequency ablation; transferrin
Mesh:
Substances:
Year: 2015 PMID: 25586821 DOI: 10.1002/adhm.201400670
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933